Lv41
520 积分 2025-03-22 加入
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission
25天前
已完结
European Myeloma Network Consensus Statement on Functional High‐Risk Multiple Myeloma
1个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group
2个月前
已完结
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data
3个月前
已完结
The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma
4个月前
已完结
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
4个月前
已完结
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
4个月前
已完结
Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity
4个月前
已完结
Monoclonal gammopathies of renal significance
4个月前
已完结